Aspirin, a widely available and inexpensive drug, has failed to improve survival or reduce recurrence rates in women with early-stage but high-risk breast cancer, according to a Harvard-led clinical ...
Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%. | Drug Discovery And ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback